LIXUDEBART
UNII STN3UZ6YBJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Lixudebart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) STN3UZ6YBJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2749515-10-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

STN3UZ6YBJ

CAS Registry Number

2749515-10-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LIXUDEBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C199065

National Cancer Institute reference terminology for clinical and research data.

INN ID

12552

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-157

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lixudebart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LIXUDEBART

Common Names & Synonyms

GAMMA1 HEAVY CHAIN HUMANIZED (1-448) (VH (HOMO SAPIENS IGHV3-21*01 (94.9%) -(IGHD) -IGHJ1*01 (92.9%), CDR-IMGT (8.8.12) (26-33.51-58.97-108)) (1-119) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 CH1 R120, CH3 E12, M14, CH2 IGHG1V39 CH2 F1.3, E1.2, S116 (CH1 R120 (216) (120-217), HINGE 1-15 (218-232), CH2 L1.3>F (236) , L1.2>E (237), P116>S (333) (233-342), CH3 E12 (358), M14 (360) (343-447), CHS K2>DEL (448)) (120-448)), (222-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV3-15*01 (84.2%) -IGKJ1*01 (100%), CDR-IMGT (6.3.9) (27-32.50-52.89-97)) (1'-107')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (228-228'':231-231'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G1 (236-PHENYLALANINE,237-GLUTAMIC ACID,333-SERINE,DE-449-LYSINE), ANTI-(HUMAN CLAUDIN-1) (HUMAN-RATTUS NORVEGICUS MONOCLONAL ALE.F02 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-RATTUS NORVEGICUS MONOCLONAL ALE.F02 .KAPPA.-CHAIN, DIMER

LIXUDEBART [INN]

LIXUDEBART [USAN]

RECOMBINANT HUMANISED IGG1 KAPPA ANTI-CLDN1 MONOCLONAL ANTIBODY ALE.F02